.png)
Chief Medical & Strategy Officer & Co-Founder
ModMed
Dr. Michael Sherling is the chief medical & strategy officer and co-founder of ModMed®. In 2014, Michael, along with his co-founder, Dan Cane, received the U.S. Chamber of Commerce’s Leadership in Healthcare Award. Michael is responsible for the development and growth of ModMed’s dermatology, gastroenterology, ophthalmology, orthopedics, plastic surgery, otolaryngology, urology and rheumatology verticals. He oversees product management in electronic health records, practice management, analytics and pathology.
With Dan Cane, he has developed novel software solutions for MIPS, ICD-10 and PQRS automation. Additionally, he is developing new products in real world effectiveness research, including disease-based registries, and retrospective and prospective studies.
Under his leadership, ModMed has established a user base of over 14,000 providers and raised over $332M in capital.
Michael is a dynamic speaker and has had the honor of speaking at the 2015 Health 2.0 Conference’s “Tools to Fix the Clinical User Experience” and the 2016 Dermatology Entrepreneurship Conference.
Michael has been a practicing dermatologist since 2006. He is currently practicing in a comprehensive skin care dermatology group in Palm Beach County, Florida. Michael is board certified by the American Board of Dermatology. Prior to relocating to Florida, he was the associate director of laser medicine and Skin Health at Brigham and Women’s Hospital in Boston and served as the associate residency program director for Harvard Medical School’s Department of Dermatology. He has several publications in peer reviewed medical literature.
Michael obtained his BS in biology at Brown University with honors in 1996, his MD from Yale School of Medicine with honors in 2002, and his MBA from Yale School of Management in 2002. He received his clinical training at Harvard Medical School, where he served as chief resident in dermatology.